-
CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer’s disease patients
Oosthoek, M., Vijverberg, E. G. B., Blujdea, E. R., Veld, S. G. J. G. I., Avilés, M. P., Zsadanyi, S. R. E., Hok-A-Hin, Y. S., Visser, A., van der Flier, W. M., Barkhof, F., del Campo, M., Schut, M. C., Bejanin, A., Alcolea, D., Teunissen, C. E. & Vermunt, L., 1 Dec 2025, In: Alzheimer's Research and Therapy. 17, 1, 169.Research output: Contribution to journal › Article* › Academic › peer-review
-
TREM2 risk variants and associated endophenotypes in alzheimer’s disease
Dijkstra, J. I. R., Vermunt, L., Venkatraghavan, V., Ozhegov, G., Coomans, E. M., Ossenkoppele, R., van de Giessen, E., Hulsman, M., de Geus, C. M., van der Flier, W. M., Sikkes, S. A. M., Barkhof, F., Tijms, B., Gouw, A. A., de Haan, W., Vijverberg, E. G. B., Pijnenburg, Y. A. L., Holstege, H., Teunissen, C. E. & van der Lee, S. J., 1 Dec 2025, In: Alzheimer's Research and Therapy. 17, 1, 57.Research output: Contribution to journal › Article* › Academic › peer-review
-
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
Bolsewig, K., Willemse, E. A. J., Sánchez-Juan, P., Rábano, A., Martínez, M., Doecke, J. D., Bellomo, G., Vermunt, L., Alcolea, D., Halbgebauer, S., in 't Veld, S., Mattsson-Carlgren, N., Veverova, K., Fowler, C. J., Boonkamp, L., Koel-Simmelink, M., Hussainali, Z., Ruiters, D. N., Gaetani, L. & Toja, A. & 12 others, , Dec 2025, In: Nature communications. 16, 1, p. 1139 1 p., 1139.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
